We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04093596
Brief Title: Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL) (UNIVERSAL)

First Submitted : September 16, 2019
First Submitted that Met QC Criteria : September 16, 2019
First Posted : September 18, 2019

Last Update Submitted that Met QC Criteria : February 18, 2022
Last Update Posted : March 7, 2022